Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Capdevila

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Molecular Oncology|July 20, 2019
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancerElena Elez, Chiara Chianese, Enrique Sanz-García, et al.
The New England Journal of Medicine|October 22, 2025
Belzutifan for Advanced Pheochromocytoma or ParagangliomaCamilo Jimenez, Mikkel Andreassen, Alice Durand, et al.
The New England Journal of Medicine|October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid CancerJulien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Annals of Surgery|January 20, 2023
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO TrialEsmée A Dijkstra, Per J Nilsson, Geke A P Hospers, et al.
The Oncologist|January 14, 2018
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)Barbara Nuñez-Valdovinos, Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, et al.
Frontiers in Nutrition|June 11, 2026
A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) studyMaria Argente-Pla, Miguel Antonio Sampedro-Nuñez, Rocio Garcia-Carbonero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2022
Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trialEsmée A Dijkstra, Geke A P Hospers, Elma Meershoek-Klein Kranenbarg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2020
PD-1 Blockade in Anaplastic Thyroid CarcinomaJaume Capdevila, Lori J Wirth, Thomas Ernst, et al.
Endocrine-Related Cancer|June 1, 2021
Treatment outcomes of advanced digestive well-differentiated grade 3 NETsLouis de Mestier, Angela Lamarca, Jorge Hernando, et al.
Molecular & Cellular Proteomics : MCP|February 29, 2020
Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular ClassificationLucía Trilla-Fuertes, Ismael Ghanem, Angelo Gámez-Pozo, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Molecular Oncology|July 20, 2019
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancerElena Elez, Chiara Chianese, Enrique Sanz-García, et al.
The New England Journal of Medicine|October 22, 2025
Belzutifan for Advanced Pheochromocytoma or ParagangliomaCamilo Jimenez, Mikkel Andreassen, Alice Durand, et al.
The New England Journal of Medicine|October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid CancerJulien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Annals of Surgery|January 20, 2023
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO TrialEsmée A Dijkstra, Per J Nilsson, Geke A P Hospers, et al.
The Oncologist|January 14, 2018
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)Barbara Nuñez-Valdovinos, Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, et al.
Frontiers in Nutrition|June 11, 2026
A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) studyMaria Argente-Pla, Miguel Antonio Sampedro-Nuñez, Rocio Garcia-Carbonero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2022
Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trialEsmée A Dijkstra, Geke A P Hospers, Elma Meershoek-Klein Kranenbarg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2020
PD-1 Blockade in Anaplastic Thyroid CarcinomaJaume Capdevila, Lori J Wirth, Thomas Ernst, et al.
Endocrine-Related Cancer|June 1, 2021
Treatment outcomes of advanced digestive well-differentiated grade 3 NETsLouis de Mestier, Angela Lamarca, Jorge Hernando, et al.
Molecular & Cellular Proteomics : MCP|February 29, 2020
Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular ClassificationLucía Trilla-Fuertes, Ismael Ghanem, Angelo Gámez-Pozo, et al.
Pageof 20